BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34571098)

  • 21. Snakebite envenoming from a global perspective: Towards an integrated approach.
    Gutiérrez JM; Williams D; Fan HW; Warrell DA
    Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bites in Australian snake handlers--Australian snakebite project (ASP-15).
    Isbister GK; Brown SG;
    QJM; 2012 Nov; 105(11):1089-95. PubMed ID: 22875778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANAVIP® interaction with western pygmy rattlesnake venom: In vitro assesment of reactivity using SE-HPLC.
    Tanner DA; Shults CA; Sanny C
    Toxicon; 2020 Dec; 188():159-163. PubMed ID: 33096151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment outcomes among snakebite patients in north-west Ethiopia-A retrospective analysis.
    Steegemans I; Sisay K; Nshimiyimana E; Gebrewold G; Piening T; Menberu Tessema E; Sahelie B; Alcoba G; Gebretsadik FS; Essink D; Collin S; Lucero E; Ritmeijer K
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010148. PubMed ID: 35139079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
    Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and characteristics of snakebite envenomations in the New York state between 2000 and 2010.
    Joslin JD; Marraffa JM; Singh H; Mularella J
    Wilderness Environ Med; 2014 Sep; 25(3):289-94. PubMed ID: 24841342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective study of clinical and epidemiological characteristics of snakebite in Napo Province, Ecuadorian Amazon.
    Patiño RSP; Salazar-Valenzuela D; Robles-Loaiza AA; Santacruz-Ortega P; Almeida JR
    Trans R Soc Trop Med Hyg; 2023 Feb; 117(2):118-127. PubMed ID: 35917814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Snake bites recorded by veterinary practices in Australia.
    Mirtschin PJ; Masci P; Paton DC; Kuchel T
    Aust Vet J; 1998 Mar; 76(3):195-8. PubMed ID: 9578756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of snake envenomation in South Korea.
    Moon JM; Chun BJ; Cho YS
    Clin Toxicol (Phila); 2023 Apr; 61(4):276-282. PubMed ID: 36939139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Envenoming and antivenom use in Australia.
    White J
    Toxicon; 1998 Nov; 36(11):1483-92. PubMed ID: 9792162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-Aided Analysis of West Sub-Saharan Africa Snakes Venom towards the Design of Epitope-Based Poly-Specific Antivenoms.
    Ros-Lucas A; Bigey P; Chippaux JP; Gascón J; Alonso-Padilla J
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development and use of immunotherapy in Africa.
    Chippaux JP
    Toxicon; 1998 Nov; 36(11):1503-6. PubMed ID: 9792164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention and improvement of clinical management of snakebite in Southern Asian countries: A proposed road map.
    Mukherjee AK; Mackessy SP
    Toxicon; 2021 Sep; 200():140-152. PubMed ID: 34280412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of snake bites in selected areas of Kenya.
    Ochola FO; Okumu MO; Muchemi GM; Mbaria JM; Gikunju JK
    Pan Afr Med J; 2018; 29():217. PubMed ID: 30100971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of snake bites by Bothrops species and Lachesis muta in Ecuador: laboratory screening of candidate antivenoms.
    Theakston RD; Laing GD; Fielding CM; Lascano AF; Touzet JM; Vallejo F; Guderian RH; Nelson SJ; Wüster W; Richards AM
    Trans R Soc Trop Med Hyg; 1995; 89(5):550-4. PubMed ID: 8560538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms.
    Smalligan R; Cole J; Brito N; Laing GD; Mertz BL; Manock S; Maudlin J; Quist B; Holland G; Nelson S; Lalloo DG; Rivadeneira G; Barragan ME; Dolley D; Eddleston M; Warrell DA; Theakston RD
    BMJ; 2004 Nov; 329(7475):1129. PubMed ID: 15539665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspective on the Therapeutics of Anti-Snake Venom.
    Gómez-Betancur I; Gogineni V; Salazar-Ospina A; León F
    Molecules; 2019 Sep; 24(18):. PubMed ID: 31505752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of snakebite and use of antivenom in Argentina.
    Dolab JA; de Roodt AR; de Titto EH; García SI; Funes R; Salomón OD; Chippaux JP
    Trans R Soc Trop Med Hyg; 2014 May; 108(5):269-76. PubMed ID: 24619585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venomous Snake and Spider Bites in Pregnancy.
    Chen E; Dotters-Katz S; Kuller JA; Varvoutis M
    Obstet Gynecol Surv; 2021 Dec; 76(12):760-767. PubMed ID: 34942652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.